StockWatch
·
Biotechnology: Commercial Physical & Biological Resarch
Quarterly ResultJun 23, 2026, 04:27 PM

ICON Q1 Revenue Up 0.9% to $2.03B; Reaffirms FY26 Guidance

AI Summary

ICON plc reported first-quarter 2026 results with revenue up 0.9% to $2,034.0 million, while GAAP diluted EPS decreased to $1.36 and adjusted diluted EPS fell to $2.50 compared to Q1 2025. The company demonstrated strong commercial momentum with net business wins of $2,880 million, a net book-to-bill of 1.42, and a 4.0% increase in backlog to $22.7 billion. ICON reaffirmed its full-year 2026 financial guidance for both revenue and adjusted diluted earnings per share.

Key Highlights

  • Q1 2026 revenue increased 0.9% to $2,034.0 million.
  • GAAP diluted EPS was $1.36, down from $1.99 in Q1 2025.
  • Adjusted diluted EPS was $2.50, compared to $3.27 in Q1 2025.
  • Net business wins totaled $2,880 million, with a net book-to-bill of 1.42.
  • Closing backlog reached $22.7 billion, a 4.0% increase from Q4 2025.
  • Adjusted EBITDA was $317.7 million, or 15.6% of revenue.
  • Free cash flow for the quarter was $136.2 million.
  • Reaffirmed full-year 2026 guidance: revenue $7,850-$8,150 million and adjusted diluted EPS $10.00-$11.00.